Format

Send to

Choose Destination
J Thorac Oncol. 2014 Dec;9(12):e86-7. doi: 10.1097/JTO.0000000000000358.

Secondary mutations at I1171 in the ALK gene confer resistance to both Crizotinib and Alectinib.

Author information

1
Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan.
PMID:
25393798
DOI:
10.1097/JTO.0000000000000358
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center